| 1 | [SID85147395] | Active | Potency | 1.2589 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 1.2589 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 2 | [SID85147395] | Active | Potency | 1.2589 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 1.2589 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 3 | [SID85147395] | Active | IC50 | 2.381 | Dose Response: Fluorescence polarization-based cell-based high throughput dose response assay for inhibitors of insulin-degrading enzyme (IDE) [AID463220, Type: confirmatory] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | IC50 | 2.381 [uM] | | BioAssay | Dose Response: Fluorescence polarization-based cell-based high throughput dose response assay for inhibitors of insulin-degrading enzyme (IDE) | | AID | 463220 | | BioAssay type | confirmatory | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 4 | [SID85147395] | Active | Potency | 2.8184 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 5 | [SID57287554] | Active | IC50 | 3.29 | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. [AID1535, Type: confirmatory] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 57287554 | | CID | 25181200 | | Outcome | Active | | IC50 | 3.29 [uM] | | BioAssay | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. | | AID | 1535 | | BioAssay type | confirmatory | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|
| 6 | [SID57287554] | Active | IC50 | 3.29 | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. [AID1535, Type: confirmatory] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 57287554 | | CID | 25181200 | | Outcome | Active | | IC50 | 3.29 [uM] | | BioAssay | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. | | AID | 1535 | | BioAssay type | confirmatory | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|
| 7 | [SID85147395] | Active | IC50 | 4.85 | Dose Response confirmation of small molecule APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID504719, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | IC50 | 4.85 [uM] | | BioAssay | Dose Response confirmation of small molecule APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 504719 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 8 | [SID85147395] | Active | Potency | 6.012 | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase [AID485367, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 6.012 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase | | AID | 485367 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 9 | [SID85147395] | Active | Potency | 7.0795 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 10 | [SID85147395] | Active | Potency | 7.0795 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 11 | [SID85147395] | Active | Potency | 7.0795 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 12 | [SID85147395] | Active | Potency | 7.0795 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 13 | [SID85147395] | Active | Potency | 8.9125 | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 14 | [SID85147395] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 15 | [SID85147395] | Active | AC50 | 10.47 | Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_Dose_CherryPick_Activity [AID588764, Type: confirmatory] | hypothetical protein CaO19.7491 [Candida albicans SC5314] [gi:68474550] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | AC50 | 10.47 [uM] | | BioAssay | Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_Dose_CherryPick_Activity | | AID | 588764 | | BioAssay type | confirmatory | | Target | hypothetical protein CaO19.7491 [Candida albicans SC5314] [gi:68474550] | | PubMed | | | Data Table |  |
|
| 16 | [SID85147395] | Active | Potency | 15.1014 | Tb PFK orthogonal confirmatory assay using ATP depletion (Kinase-Glo Plus) as an alternative measure of Tb PFK activity: Hit Validation [AID504636, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 15.1014 [uM] | | BioAssay | Tb PFK orthogonal confirmatory assay using ATP depletion (Kinase-Glo Plus) as an alternative measure of Tb PFK activity: Hit Validation | | AID | 504636 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 17 | [SID85147395] | Active | Potency | 16.9441 | Inhibitors of T. brucei phosphofructokinase: Hit Validation [AID504637, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 16.9441 [uM] | | BioAssay | Inhibitors of T. brucei phosphofructokinase: Hit Validation | | AID | 504637 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 18 | [SID85147395] | Active | Potency | 19.9526 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 19 | [SID85147395] | Active | IC50 | 30.08 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens [AID624330, Type: confirmatory] | RACGAP1 gene product [Homo sapiens] [gi:21361397] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | IC50 | 30.08 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens | | AID | 624330 | | BioAssay type | confirmatory | | Target | RACGAP1 gene product [Homo sapiens] [gi:21361397] | | PubMed | | | Data Table |  |
|
| 20 | [SID57287554] | Active | IC50 | 52.5 | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay [AID1655, Type: confirmatory] | phosphomannomutase 2 [Homo sapiens] [gi:4557839] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 57287554 | | CID | 25181200 | | Outcome | Active | | IC50 | 52.5 [uM] | | BioAssay | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay | | AID | 1655 | | BioAssay type | confirmatory | | Target | phosphomannomutase 2 [Homo sapiens] [gi:4557839] | | PubMed | | | Data Table |  |
|
| 21 | [SID57287554] | Active | IC50 | 52.5 | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay [AID1655, Type: confirmatory] | phosphomannomutase 2 [Homo sapiens] [gi:4557839] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 57287554 | | CID | 25181200 | | Outcome | Active | | IC50 | 52.5 [uM] | | BioAssay | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay | | AID | 1655 | | BioAssay type | confirmatory | | Target | phosphomannomutase 2 [Homo sapiens] [gi:4557839] | | PubMed | | | Data Table |  |
|
| 22 | [SID57287554] | Active | | | Toxicity Screening of PMI Inhibitors in Hela cells [AID1620, Type: other] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 57287554 | | CID | 25181200 | | Outcome | Active | | BioAssay | Toxicity Screening of PMI Inhibitors in Hela cells | | AID | 1620 | | BioAssay type | other | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|
| 23 | [SID57287554] | Active | | | Toxicity Screening of PMI Inhibitors in Hela cells [AID1620, Type: other] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 57287554 | | CID | 25181200 | | Outcome | Active | | BioAssay | Toxicity Screening of PMI Inhibitors in Hela cells | | AID | 1620 | | BioAssay type | other | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|
| 24 | [SID85147395] | Active | | | Fluorescence polarization-based cell-based high throughput confirmation assay for inhibitors of insulin-degrading enzyme (IDE) [AID435028, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based high throughput confirmation assay for inhibitors of insulin-degrading enzyme (IDE) | | AID | 435028 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 25 | [SID85147395] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 26 | [SID85147395] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 27 | [SID85147395] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 28 | [SID85147395] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 29 | [SID85147395] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 30 | [SID85147395] | Active | | | uHTS identification of small molecule modulators of myocardial damage [AID588492, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | uHTS identification of small molecule modulators of myocardial damage | | AID | 588492 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID85147395] | Active | | | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies [AID588358, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies | | AID | 588358 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID85147395] | Active | | | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID504690, Type: screening] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay | | AID | 504690 | | BioAssay type | screening | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 33 | [SID85147395] | Active | | | Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity [AID540336, Type: screening] | hypothetical protein CaO19.7491 [Candida albicans SC5314] [gi:68474550] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 540336 | | BioAssay type | screening | | Target | hypothetical protein CaO19.7491 [Candida albicans SC5314] [gi:68474550] | | PubMed | | | Data Table |  |
|
| 34 | [SID85147395] | Active | | | Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA) [AID602163, Type: screening] | MSRA protein [Bos taurus] [gi:73586699] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA) | | AID | 602163 | | BioAssay type | screening | | Target | MSRA protein [Bos taurus] [gi:73586699] | | PubMed | | | Data Table |  |
|
| 35 | [SID85147395] | Active | | | uHTS Colorimetric assay for identification of inhibitors of Scp-1 [AID493091, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | uHTS Colorimetric assay for identification of inhibitors of Scp-1 | | AID | 493091 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 36 | [SID85147395] | Active | | | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity [AID504582, Type: screening] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504582 | | BioAssay type | screening | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 37 | [SID85147395] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | PADI4 gene product [Homo sapiens] [gi:216548487] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | PADI4 gene product [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 38 | [SID85147395] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | PADI4 gene product [Homo sapiens] [gi:216548487] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | PADI4 gene product [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 39 | [SID85147395] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) [AID488796, Type: screening] | PADI4 gene product [Homo sapiens] [gi:216548487] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) | | AID | 488796 | | BioAssay type | screening | | Target | PADI4 gene product [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 40 | [SID85147395] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) [AID488796, Type: screening] | PADI4 gene product [Homo sapiens] [gi:216548487] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) | | AID | 488796 | | BioAssay type | screening | | Target | PADI4 gene product [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 41 | [SID85147395] | Active | | | Luminescence-based biochemical high throughput confirmation assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID651612, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Luminescence-based biochemical high throughput confirmation assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 651612 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 42 | [SID85147395] | Active | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID602281, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 602281 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 43 | [SID85147395] | Active | | | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity [AID652197, Type: screening] | ERAP1 protein [Homo sapiens] [gi:21315078] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652197 | | BioAssay type | screening | | Target | ERAP1 protein [Homo sapiens] [gi:21315078] | | PubMed | | | Data Table |  |
|
| 44 | [SID85147395] | Active | | | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity [AID652197, Type: screening] | ERAP1 protein [Homo sapiens] [gi:21315078] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652197 | | BioAssay type | screening | | Target | ERAP1 protein [Homo sapiens] [gi:21315078] | | PubMed | | | Data Table |  |
|
| 45 | [SID85147395] | Active | | | Single concentration confirmation of uHTS for APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493152, Type: screening] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493152 | | BioAssay type | screening | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 46 | [SID85147395] | Active | | | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493012, Type: screening] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493012 | | BioAssay type | screening | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 47 | [SID85147395] | Active | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) [AID434962, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) | | AID | 434962 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 48 | [SID85147395] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] | | PubMed | | | Data Table |  |
|
| 49 | [SID85147395] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 50 | [SID85147395] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 85147395 | | CID | 25181200 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|